Literature DB >> 21555680

Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study.

Toshiharu Ninomiya1, Tomoyuki Ohara, Yoichiro Hirakawa, Daigo Yoshida, Yasufumi Doi, Jun Hata, Shigenobu Kanba, Toru Iwaki, Yutaka Kiyohara.   

Abstract

The associations between blood pressure and dementia have been inconclusive. We followed up a total of 668 community-dwelling Japanese individuals without dementia, aged 65 to 79 years, for 17 years and examined the associations of late-life and midlife hypertension with the risk of vascular dementia and Alzheimer disease using the Cox proportional hazards model. During the follow-up, 76 subjects experienced vascular dementia and 123 developed Alzheimer disease. The age- and sex-adjusted incidence of vascular dementia significantly increased with elevated late-life blood pressure levels (normal: 2.3, prehypertension: 8.4, stage 1 hypertension: 12.6, and stage 2 hypertension: 18.9 per 1000 person-years; P(trend)<0.001), whereas no such association was observed for Alzheimer disease (P(trend)=0.88). After adjusting for potential confounding factors, subjects with prehypertension and stage 1 or stage 2 hypertension had 3.0-fold, 4.5-fold, and 5.6-fold greater risk of vascular dementia, respectively, compared with subjects with normal blood pressure. Likewise, there was a positive association of midlife blood pressure levels with the risk of vascular dementia but not with the risk of Alzheimer disease. Compared with those without hypertension in both midlife and late life, subjects with midlife hypertension had an ≈5-fold greater risk of vascular dementia, regardless of late-life blood pressure levels. Our findings suggest that midlife hypertension and late-life hypertension are significant risk factors for the late-life onset of vascular dementia but not for that of Alzheimer disease in a general Japanese population. Midlife hypertension is especially strongly associated with a greater risk of vascular dementia, regardless of late-life blood pressure levels.

Entities:  

Mesh:

Year:  2011        PMID: 21555680     DOI: 10.1161/HYPERTENSIONAHA.110.163055

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  71 in total

Review 1.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

Review 2.  Neurovascular and Cognitive Dysfunction in Hypertension.

Authors:  Costantino Iadecola; Rebecca F Gottesman
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

Review 3.  Cognitive and physical function in chronic kidney disease.

Authors:  Daniel E Weiner; Stephen L Seliger
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

4.  Does education improve cognitive performance four decades after school completion?

Authors:  Nicole Schneeweis; Vegard Skirbekk; Rudolf Winter-Ebmer
Journal:  Demography       Date:  2014-04

5.  Late-Life Body Mass Index, Rapid Weight Loss, Apolipoprotein E ε4 and the Risk of Cognitive Decline and Incident Dementia.

Authors:  S P Bell; D Liu; L R Samuels; A S Shah; K A Gifford; T J Hohman; A L Jefferson
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

6.  Hypertension and dementia.

Authors:  Costantino Iadecola
Journal:  Hypertension       Date:  2014-04-28       Impact factor: 10.190

Review 7.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

Review 8.  Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

9.  Aortic Stiffness is Associated with Increased Risk of Incident Dementia in Older Adults.

Authors:  Chendi Cui; Akira Sekikawa; Lewis H Kuller; Oscar L Lopez; Anne B Newman; Allison L Kuipers; Rachel H Mackey
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 10.  Do angiotensin receptor blockers protect against Alzheimer's disease?

Authors:  Hitomi Kurinami; Munehisa Shimamura; Naoyuki Sato; Hironori Nakagami; Ryuichi Morishita
Journal:  Drugs Aging       Date:  2013-06       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.